Quality Indicators of Transanal Total Mesorectal Excision (TaTME) for Rectal Cancer

Detalhes bibliográficos
Autor(a) principal: Martínez,María Labalde
Data de Publicação: 2021
Outros Autores: Lopez,Alfredo Vivas, Jimenez,Juan Ocaña, García,Cristina Nevado, Villar,Oscar García, Gonzalez,Eduardo Rubio, Borda,Francisco Javier García, Vigo,Felipe Cruz, Herrero,Eduardo Ferrero
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Journal of Coloproctology (Rio de Janeiro. Online)
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S2237-93632021000400411
Resumo: Abstract Introduction Transanal total mesorectal excision (TaTME) has revolutionized the surgical techniques for lower-third rectal cancer. The aim of the present study was to analyze the outcomes of quality indicators of TaTME for rectal cancer compared with laparoscopic TME (LaTME). Methods A cohort prospective study with 50 (14 female and 36male) patients, with a mean age of 67 (range: 55.75 to 75.25) years, who underwent surgery for rectal cancer. In total, 20 patients underwent TaTME, and 30, LaTME. Every TaTME procedure was performed by experienced colorectal surgeons. The sample was divided into two groups (TaTME and LaTME), and the quality indicators of the surgery for rectal cancer were analyzed. Results There were no statistically significant differences regarding the patients and the main characteristics of the tumor (age, gender, American Society of Anesthesiologists [ASA] score, body mass index [BMI], tumoral stage, neoadjuvant therapy, and distance from the tumor to the external anal margin) between the two groups. The rates of: postoperativemorbidity (TaTME: 35%; LaTME: 30%; p=0.763);mortality (0%); anastomotic leak (TaTME: 10%; LaTME: 13%; p=0.722); wound infection (TaTME: 0%; LaTME: 3.3%; p=0.409); reoperation (TaTME: 5%; LaTME: 6.6%; p=0.808); and readmission (TaTME: 5%; LaTME: 0%; p=0.400), as well as the length of the hospital stay (TaTME: 13.5 days; LaTME: 11 days; p=0.538), were similar in both groups. There were no statistically significant differences in the rates of positive circumferential resection margin (TaTME: 5%; LaTME: 3.3%; p=0.989) and positive distal resection margin (TaTME: 0%; LaTME: 3.3%; p=0.400), the completeness of the TME (TaTME: 100%; LaTME: 100%), and the number of lymph nodes harvested (TaTME: 15; LaTME: 15.5; p=0.882) between two groups. Conclusion Transanal total mesorectal excision is a safe and feasible surgical procedure for middle/lower-third rectal cancer.
id SBCP-1_d0ee542f6e726d20c537d4db3b38dfa7
oai_identifier_str oai:scielo:S2237-93632021000400411
network_acronym_str SBCP-1
network_name_str Journal of Coloproctology (Rio de Janeiro. Online)
repository_id_str
spelling Quality Indicators of Transanal Total Mesorectal Excision (TaTME) for Rectal Cancerrectal cancertransanal total mesorectal excision rectal cancer surgeryTaTMEquality indicators of rectal cancer surgeryAbstract Introduction Transanal total mesorectal excision (TaTME) has revolutionized the surgical techniques for lower-third rectal cancer. The aim of the present study was to analyze the outcomes of quality indicators of TaTME for rectal cancer compared with laparoscopic TME (LaTME). Methods A cohort prospective study with 50 (14 female and 36male) patients, with a mean age of 67 (range: 55.75 to 75.25) years, who underwent surgery for rectal cancer. In total, 20 patients underwent TaTME, and 30, LaTME. Every TaTME procedure was performed by experienced colorectal surgeons. The sample was divided into two groups (TaTME and LaTME), and the quality indicators of the surgery for rectal cancer were analyzed. Results There were no statistically significant differences regarding the patients and the main characteristics of the tumor (age, gender, American Society of Anesthesiologists [ASA] score, body mass index [BMI], tumoral stage, neoadjuvant therapy, and distance from the tumor to the external anal margin) between the two groups. The rates of: postoperativemorbidity (TaTME: 35%; LaTME: 30%; p=0.763);mortality (0%); anastomotic leak (TaTME: 10%; LaTME: 13%; p=0.722); wound infection (TaTME: 0%; LaTME: 3.3%; p=0.409); reoperation (TaTME: 5%; LaTME: 6.6%; p=0.808); and readmission (TaTME: 5%; LaTME: 0%; p=0.400), as well as the length of the hospital stay (TaTME: 13.5 days; LaTME: 11 days; p=0.538), were similar in both groups. There were no statistically significant differences in the rates of positive circumferential resection margin (TaTME: 5%; LaTME: 3.3%; p=0.989) and positive distal resection margin (TaTME: 0%; LaTME: 3.3%; p=0.400), the completeness of the TME (TaTME: 100%; LaTME: 100%), and the number of lymph nodes harvested (TaTME: 15; LaTME: 15.5; p=0.882) between two groups. Conclusion Transanal total mesorectal excision is a safe and feasible surgical procedure for middle/lower-third rectal cancer.Sociedade Brasileira de Coloproctologia2021-12-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S2237-93632021000400411Journal of Coloproctology (Rio de Janeiro) v.41 n.4 2021reponame:Journal of Coloproctology (Rio de Janeiro. Online)instname:Sociedade Brasileira de Coloproctologia (SBCP)instacron:SBCP10.1055/s-0041-1736640info:eu-repo/semantics/openAccessMartínez,María LabaldeLopez,Alfredo VivasJimenez,Juan OcañaGarcía,Cristina NevadoVillar,Oscar GarcíaGonzalez,Eduardo RubioBorda,Francisco Javier GarcíaVigo,Felipe CruzHerrero,Eduardo Ferreroeng2022-01-20T00:00:00Zoai:scielo:S2237-93632021000400411Revistahttp://www.scielo.br/scielo.php?script=sci_serial&pid=2237-9363&lng=pt&nrm=isohttps://old.scielo.br/oai/scielo-oai.php||sbcp@sbcp.org.br2317-64232237-9363opendoar:2022-01-20T00:00Journal of Coloproctology (Rio de Janeiro. Online) - Sociedade Brasileira de Coloproctologia (SBCP)false
dc.title.none.fl_str_mv Quality Indicators of Transanal Total Mesorectal Excision (TaTME) for Rectal Cancer
title Quality Indicators of Transanal Total Mesorectal Excision (TaTME) for Rectal Cancer
spellingShingle Quality Indicators of Transanal Total Mesorectal Excision (TaTME) for Rectal Cancer
Martínez,María Labalde
rectal cancer
transanal total mesorectal excision rectal cancer surgery
TaTME
quality indicators of rectal cancer surgery
title_short Quality Indicators of Transanal Total Mesorectal Excision (TaTME) for Rectal Cancer
title_full Quality Indicators of Transanal Total Mesorectal Excision (TaTME) for Rectal Cancer
title_fullStr Quality Indicators of Transanal Total Mesorectal Excision (TaTME) for Rectal Cancer
title_full_unstemmed Quality Indicators of Transanal Total Mesorectal Excision (TaTME) for Rectal Cancer
title_sort Quality Indicators of Transanal Total Mesorectal Excision (TaTME) for Rectal Cancer
author Martínez,María Labalde
author_facet Martínez,María Labalde
Lopez,Alfredo Vivas
Jimenez,Juan Ocaña
García,Cristina Nevado
Villar,Oscar García
Gonzalez,Eduardo Rubio
Borda,Francisco Javier García
Vigo,Felipe Cruz
Herrero,Eduardo Ferrero
author_role author
author2 Lopez,Alfredo Vivas
Jimenez,Juan Ocaña
García,Cristina Nevado
Villar,Oscar García
Gonzalez,Eduardo Rubio
Borda,Francisco Javier García
Vigo,Felipe Cruz
Herrero,Eduardo Ferrero
author2_role author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Martínez,María Labalde
Lopez,Alfredo Vivas
Jimenez,Juan Ocaña
García,Cristina Nevado
Villar,Oscar García
Gonzalez,Eduardo Rubio
Borda,Francisco Javier García
Vigo,Felipe Cruz
Herrero,Eduardo Ferrero
dc.subject.por.fl_str_mv rectal cancer
transanal total mesorectal excision rectal cancer surgery
TaTME
quality indicators of rectal cancer surgery
topic rectal cancer
transanal total mesorectal excision rectal cancer surgery
TaTME
quality indicators of rectal cancer surgery
description Abstract Introduction Transanal total mesorectal excision (TaTME) has revolutionized the surgical techniques for lower-third rectal cancer. The aim of the present study was to analyze the outcomes of quality indicators of TaTME for rectal cancer compared with laparoscopic TME (LaTME). Methods A cohort prospective study with 50 (14 female and 36male) patients, with a mean age of 67 (range: 55.75 to 75.25) years, who underwent surgery for rectal cancer. In total, 20 patients underwent TaTME, and 30, LaTME. Every TaTME procedure was performed by experienced colorectal surgeons. The sample was divided into two groups (TaTME and LaTME), and the quality indicators of the surgery for rectal cancer were analyzed. Results There were no statistically significant differences regarding the patients and the main characteristics of the tumor (age, gender, American Society of Anesthesiologists [ASA] score, body mass index [BMI], tumoral stage, neoadjuvant therapy, and distance from the tumor to the external anal margin) between the two groups. The rates of: postoperativemorbidity (TaTME: 35%; LaTME: 30%; p=0.763);mortality (0%); anastomotic leak (TaTME: 10%; LaTME: 13%; p=0.722); wound infection (TaTME: 0%; LaTME: 3.3%; p=0.409); reoperation (TaTME: 5%; LaTME: 6.6%; p=0.808); and readmission (TaTME: 5%; LaTME: 0%; p=0.400), as well as the length of the hospital stay (TaTME: 13.5 days; LaTME: 11 days; p=0.538), were similar in both groups. There were no statistically significant differences in the rates of positive circumferential resection margin (TaTME: 5%; LaTME: 3.3%; p=0.989) and positive distal resection margin (TaTME: 0%; LaTME: 3.3%; p=0.400), the completeness of the TME (TaTME: 100%; LaTME: 100%), and the number of lymph nodes harvested (TaTME: 15; LaTME: 15.5; p=0.882) between two groups. Conclusion Transanal total mesorectal excision is a safe and feasible surgical procedure for middle/lower-third rectal cancer.
publishDate 2021
dc.date.none.fl_str_mv 2021-12-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S2237-93632021000400411
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S2237-93632021000400411
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1055/s-0041-1736640
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Sociedade Brasileira de Coloproctologia
publisher.none.fl_str_mv Sociedade Brasileira de Coloproctologia
dc.source.none.fl_str_mv Journal of Coloproctology (Rio de Janeiro) v.41 n.4 2021
reponame:Journal of Coloproctology (Rio de Janeiro. Online)
instname:Sociedade Brasileira de Coloproctologia (SBCP)
instacron:SBCP
instname_str Sociedade Brasileira de Coloproctologia (SBCP)
instacron_str SBCP
institution SBCP
reponame_str Journal of Coloproctology (Rio de Janeiro. Online)
collection Journal of Coloproctology (Rio de Janeiro. Online)
repository.name.fl_str_mv Journal of Coloproctology (Rio de Janeiro. Online) - Sociedade Brasileira de Coloproctologia (SBCP)
repository.mail.fl_str_mv ||sbcp@sbcp.org.br
_version_ 1752126479260450816